Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 67Lung Neoplasms 29Brain Neoplasms 11Head and Neck Neoplasms 10Neoplasms 9Esophageal Neoplasms 9Breast Neoplasms 8Adenocarcinoma of Lung 8Adenocarcinoma Of Esophagus 7Glioblastoma 6Gliosarcoma 5Esophageal Squamous Cell Carcinoma 5NSCLC 4Central Nervous System Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Colonic Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Stomach Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Neuroblastoma 2Lymphoid Interstitial Pneumonia 2Laryngeal Diseases 2Glioma 2

Interventions

icotinib 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non-Small-Cell Lung × Gefitinib × Clear all
NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

The First Affiliated Hospital of Soochow University

Phase NA Unknown
66 enrolled
Thoracic

Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡